Boehringer Ingelheim ranks as a ”Global Player“ among the world’s most research-intensive pharmaceutical enterprises and employs a staff of over 47,700 in 142 affiliated companies. Of its global revenues totalling 13,3 billion Euros in 2014, Research & Development expenditure in Prescription Medicines corresponds to 23.1% of the net sales generated in this business. Being a privately held company with the ability to have an innovative and long term view, our focus is on scientific discoveries that improve patients' lives and we equate success as a pharmaceutical company with the steady introduction of truly innovative medicines.At Boehringer Ingelheim, we are committed to delivering value through innovation. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. Boehringer Ingelheim, including Boehringer Ingelheim (Hong Kong) Ltd, is an equal opportunity employer. Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment background checks.The Hong Kong operations started in 1977 and we are among the Top 10 leading pharmaceutical companies in Hong Kong.
Boehringer Ingelheim ranks as a ”Global Player“ among the world’s most research-intensive pharmaceutical enterprises and employs a staff of over 47,700 in 142 affiliated companies. Of its global revenues totalling 13,3 billion Euros in 2014, Research & Development expenditure in Prescription Medicines corresponds to 23.1% of the net sales generated in this business. Being a privately held company with the ability to have an innovative and long term view, our focus is on scientific discoveries that improve patients' lives and we equate success as a pharmaceutical company with the steady introduction of truly innovative medicines.At Boehringer Ingelheim, we are committed to delivering value through innovation. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. Boehringer Ingelheim, including Boehringer Ingelheim (Hong Kong) Ltd, is an equal opportunity employer. Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment background checks.The Hong Kong operations started in 1977 and we are among the Top 10 leading pharmaceutical companies in Hong Kong.
Boehringer Ingelheim ranks as a ”Global Player“ among the world’s most research-intensive pharmaceutical enterprises and employs a staff of over 47,700 in 142 affiliated companies. Of its global revenues totalling 13,3 billion Euros in 2014, Research & Development expenditure in Prescription Medicines corresponds to 23.1% of the net sales generated in this business. Being a privately held company with the ability to have an innovative and long term view, our focus is on scientific discoveries that improve patients' lives and we equate success as a pharmaceutical company with the steady introduction of truly innovative medicines.At Boehringer Ingelheim, we are committed to delivering value through innovation. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. Boehringer Ingelheim, including Boehringer Ingelheim (Hong Kong) Ltd, is an equal opportunity employer. Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment background checks.The Hong Kong operations started in 1977 and we are among the Top 10 leading pharmaceutical companies in Hong Kong.